FR2532306A1 - BASIC ACETANILIDES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THE SAME - Google Patents
BASIC ACETANILIDES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THE SAME Download PDFInfo
- Publication number
- FR2532306A1 FR2532306A1 FR8313761A FR8313761A FR2532306A1 FR 2532306 A1 FR2532306 A1 FR 2532306A1 FR 8313761 A FR8313761 A FR 8313761A FR 8313761 A FR8313761 A FR 8313761A FR 2532306 A1 FR2532306 A1 FR 2532306A1
- Authority
- FR
- France
- Prior art keywords
- radical
- basic
- acetanilides
- formula iii
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000008061 acetanilides Chemical class 0.000 title claims abstract description 14
- 238000000034 method Methods 0.000 title claims description 9
- 239000003814 drug Substances 0.000 title claims description 6
- 238000002360 preparation method Methods 0.000 title claims description 6
- 150000001875 compounds Chemical class 0.000 claims abstract description 14
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 5
- 239000003416 antiarrhythmic agent Substances 0.000 claims abstract description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 3
- 239000001257 hydrogen Substances 0.000 claims abstract 3
- 230000003288 anthiarrhythmic effect Effects 0.000 claims abstract 2
- -1 nitro, amino Chemical group 0.000 claims description 15
- 238000001816 cooling Methods 0.000 claims description 14
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 6
- 150000001412 amines Chemical class 0.000 claims description 4
- 239000012442 inert solvent Substances 0.000 claims description 4
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 3
- 241001331845 Equus asinus x caballus Species 0.000 claims description 2
- 125000003282 alkyl amino group Chemical group 0.000 claims description 2
- 125000004414 alkyl thio group Chemical group 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 239000003589 local anesthetic agent Substances 0.000 claims description 2
- 125000005415 substituted alkoxy group Chemical group 0.000 claims description 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical class C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 2
- 125000001246 bromo group Chemical group Br* 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical class OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 150000001649 bromium compounds Chemical class 0.000 claims 1
- 150000003841 chloride salts Chemical class 0.000 claims 1
- 125000006312 cyclopentyl amino group Chemical group [H]N(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 125000006317 cyclopropyl amino group Chemical group 0.000 claims 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 claims 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical class OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 1
- 150000002688 maleic acid derivatives Chemical class 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000004953 trihalomethyl group Chemical group 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 40
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 26
- FZERHIULMFGESH-UHFFFAOYSA-N N-phenylacetamide Chemical compound CC(=O)NC1=CC=CC=C1 FZERHIULMFGESH-UHFFFAOYSA-N 0.000 description 14
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 229960001413 acetanilide Drugs 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- 238000002844 melting Methods 0.000 description 9
- 230000008018 melting Effects 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000013067 intermediate product Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- YDPXZINXUVCZKH-UHFFFAOYSA-N 2-ethoxy-6-methylaniline Chemical compound CCOC1=CC=CC(C)=C1N YDPXZINXUVCZKH-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- NISGSNTVMOOSJQ-UHFFFAOYSA-N cyclopentanamine Chemical compound NC1CCCC1 NISGSNTVMOOSJQ-UHFFFAOYSA-N 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- PQXGRUUJIFRFGC-UHFFFAOYSA-N 2-amino-3-methylbenzonitrile Chemical compound CC1=CC=CC(C#N)=C1N PQXGRUUJIFRFGC-UHFFFAOYSA-N 0.000 description 1
- TWZJXDOMOGUSDA-UHFFFAOYSA-N 2-chloro-3,3,3-trifluoro-n-phenylpropanamide Chemical compound FC(F)(F)C(Cl)C(=O)NC1=CC=CC=C1 TWZJXDOMOGUSDA-UHFFFAOYSA-N 0.000 description 1
- BBQZKZIIRKKRBD-UHFFFAOYSA-N 2-chloro-n-(2-chloro-6-methylphenyl)acetamide Chemical compound CC1=CC=CC(Cl)=C1NC(=O)CCl BBQZKZIIRKKRBD-UHFFFAOYSA-N 0.000 description 1
- HHQVWQLHIHVNGR-UHFFFAOYSA-N 2-chloro-n-(2-methyl-6-nitrophenyl)acetamide Chemical compound CC1=CC=CC([N+]([O-])=O)=C1NC(=O)CCl HHQVWQLHIHVNGR-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical group CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- NMGWDDZQZAYRNZ-UHFFFAOYSA-N 3-fluoro-n-phenylpropanamide Chemical compound FCCC(=O)NC1=CC=CC=C1 NMGWDDZQZAYRNZ-UHFFFAOYSA-N 0.000 description 1
- BOHCMQZJWOGWTA-UHFFFAOYSA-N 3-methylbenzonitrile Chemical compound CC1=CC=CC(C#N)=C1 BOHCMQZJWOGWTA-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 1
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical group [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 description 1
- FCLZCOCSZQNREK-UHFFFAOYSA-N Pyrrolidine, hydrochloride Chemical compound Cl.C1CCNC1 FCLZCOCSZQNREK-UHFFFAOYSA-N 0.000 description 1
- 238000000297 Sandmeyer reaction Methods 0.000 description 1
- 241000212342 Sium Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 229940051881 anilide analgesics and antipyretics Drugs 0.000 description 1
- 150000003931 anilides Chemical class 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- MOOAHMCRPCTRLV-UHFFFAOYSA-N boron sodium Chemical compound [B].[Na] MOOAHMCRPCTRLV-UHFFFAOYSA-N 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- HDITUCONWLWUJR-UHFFFAOYSA-N diethylazanium;chloride Chemical compound [Cl-].CC[NH2+]CC HDITUCONWLWUJR-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- FRIJBUGBVQZNTB-UHFFFAOYSA-M magnesium;ethane;bromide Chemical compound [Mg+2].[Br-].[CH2-]C FRIJBUGBVQZNTB-UHFFFAOYSA-M 0.000 description 1
- IFYZUHPFZSHBIW-UHFFFAOYSA-N n-(2-methyl-6-nitrophenyl)-2-piperidin-1-ylacetamide Chemical compound CC1=CC=CC([N+]([O-])=O)=C1NC(=O)CN1CCCCC1 IFYZUHPFZSHBIW-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
ACETANILIDES BASIQUES NOUVEAUX DE FORMULEIII (CF DESSIN DANS BOPI) DANS LAQUELLE: R EST UN RADICAL HYDROGENE OU ALKYLE EVENTUELLEMENT SUBSTITUE, R EST UN RADICAL HALOGENE, ALCOXY EVENTUELLEMENT SUBSTITUE, ALKYLTHIO EVENTUELLEMENT SUBSTITUE, NITRO, AMINO OU ALKYLAMINO EVENTUELLEMENT SUBSTITUE, PROPIONYLE OU TRIFLUOROMETHYLE, R ET R POUVANT ETRE IDENTIQUES OU DIFFERENTS, ET R EST UN RADICAL BASIQUE, ET LEURS SELS UTILISABLES EN PHARMACOLOGIE. CES COMPOSES NOUVEAUX SONT UTILISES DE PREFERENCE COMME ANESTHESIQUES LOCAUX ET COMME ANTI-ARYTHMIQUES.NEW BASIC ACETANILIDES OF FORMULA III (CF DRAWING IN BOPI) IN WHICH: R IS A HYDROGEN OR ALKYL RADICAL POSSIBLY SUBSTITUTED, R IS A HALOGEN RADICAL, ALCOXY POSSIBLY SUBSTITUTED, ALKYLTHIO POSSIBLY ALKYLTHIO, POSSIBLY SUBSTITUTED, OR SUBSTITUTED ALKYLTHIO, NOW ALKYLTHIO, NOW SUBSTROUTINE, OR THEN ALKYLTHIO R AND R MAY BE THE SAME OR DIFFERENT, AND R IS A BASIC RADICAL, AND THEIR SALTS USE IN PHARMACOLOGY. THESE NEW COMPOUNDS ARE PREFERABLY USED AS LOCAL ANESTHESICS AND AS ANTI-ARRHYTHMICS.
Description
Acétanilides basiques, procédé pour leur préparationBasic acetanilides, process for their preparation
et médicaments en contenant.and drugs containing it.
La présente invention porte sur des acétanili- The present invention relates to acetanilines
des basiques nouveaux, un procédé pour leur préparation et des médicaments en contenant. La présente invention a pour but des composés nouveaux qui puissent être utilisés par exemple comme anesthésiques locaux et comme agents anti-arythmiques et qui soient moins toxiques et plus efficaces que les new basics, a process for their preparation and drugs containing them. The present invention aims at novel compounds which can be used for example as local anesthetics and as anti-arrhythmic agents and which are less toxic and more effective than the
composés connus.known compounds.
Un autre but de la présente invention est de fournir des procédés de préparation de ces composés nouveaux simples à mettre en oeuvre et économiquement intéressants. Ces buts sont atteints avec les acétanilides basiques nouveaux de l'invention de formule III R 1 R Another object of the present invention is to provide processes for the preparation of these novel compounds which are simple to implement and economically advantageous. These aims are achieved with the novel basic acetanilides of the invention of formula III R 1 R
/ Y X NH-J-CH -R III/ Y X NH-J-CH-R III
R 4 dans laquelle R est un radical hydrogène ou un alkyle éventuellement substitué, R 4 est un radical halogène, alcoxy éventuellement substitué, alkylthio éventuellement substitué, R 4 in which R is a hydrogen radical or an optionally substituted alkyl, R 4 is a halogen radical, optionally substituted alkoxy, optionally substituted alkylthio,
nitro, amino ou alkylamino éventuellement substi- nitro, amino or optionally substituted alkylamino
tué, propionyle ou trifluorométhyle, R 1 et R pou- killed, propionyl or trifluoromethyl, R 1 and R
vant être identiques ou différents, et R 5 est un radical basique, be identical or different, and R 5 is a basic radical,
et leurs sels utilisables en pharmacologie. and their salts for use in pharmacology.
Le procédé de l'invention pour la préparation des acétanilides basiques nouveaux de formule III R 1 The process of the invention for the preparation of novel basic acetanilides of formula III R 1
-CH 2-R 5-CH 2-R 5
III R 4III R 4
dans laquelle R 1, R 4 et R 5 ont la signification indi- in which R 1, R 4 and R 5 have the indi-
quée plus haut et leurs sels utilisables en pharmaco- above and their salts for use in pharmaco-
logie est caractérisé par le fait qu'on fait réagir une aniline de formule I Qr NH 2 I R - dans laquelle R 1 et R ont la signification indiquée plus haut, avec un composé halogéné de formule II X_C 0-CH 2 Hal II dans laquelle The invention is characterized in that an aniline of formula I in which R 1 and R are as defined above is reacted with a halogenated compound of formula II ## STR2 ## wherein
X est-un groupe hydroxyle, un radical ester, un halo- X is a hydroxyl group, an ester radical, a halogen,
génure, un radical amide ou un radical anhydride ou un autre groupe de départ approprié, et Hal est un atome d'halogène ou un autre groupe de dé- an amide radical or an anhydride radical or other suitable starting group, and Hal is a halogen atom or another group of
part approprié, avec refroidissement ou à la tempéra- appropriate share, with cooling or at room temperature
ture ambiante, dans un solvant et en présence d'une base, pour obtenir un composé de formule IV ambient temperature, in a solvent and in the presence of a base, to obtain a compound of formula IV
R 1R 1
NH-CO-CH 2-Hal IVNH-CO-CH 2-Hal IV
4 IV4 IV
R 1 4R 1 4
dans laquelle R 1, R et Hal ont la signification indi- in which R 1, R and Hal have the indicated meaning
quée plus haut, on fait réagir ensuite ces composés dans un solvant inerte et à température élevée avec above, these compounds are then reacted in an inert solvent and at elevated temperature with
une amine cédant le radical R 5, et on transforme éven- an amine yielding the radical R 5, and optionally converting
tuellement les composés obtenus en leurs sels utilisa- the compounds obtained in their salts
bles en pharmacologie.in pharmacology.
On prépare les produits intermédiaire de for- Intermediate products of
mule IV de la manière suivante: on fait agir des acides gras halogénés ou des dérivés appropriés comme mule IV as follows: halogenated fatty acids or suitable derivatives are
leurs esters, halogénures (par exemple chlorure d'aci- their esters, halides (e.g.
de ou bromure d'acide), amides ou anhydrides sur une acid or bromide), amides or anhydrides on a
aniline, avec refroidissement ou à la température am- aniline, with cooling or at ambient temperature
biante, dans un solvant, par exemple acétone, acide biante, in a solvent, for example acetone, acid
acétique, acétate d'éthyle, chloroforme, et en présen- acetic acid, ethyl acetate, chloroform, and in
ce d'une base telle que carbonate de sodium, carbona this of a base such as sodium carbonate, carbona
te de potassium, bicarbonate de sodium ou de potas- potassium, sodium bicarbonate or potassium
sium, acétate de sodium, ou dans un tampon aqueux à sium, sodium acetate, or in aqueous buffer with
l'acétate de sodium On fait-réagir les halogéno- sodium acetate The halogeno-halogenated
acétanilides de formule générale IV avec une amine dans un solvant inerte, de préférence le benzène, et acetanilides of general formula IV with an amine in an inert solvent, preferably benzene, and
à la température élevée.at high temperature.
On peut aussi préparer les acètanilides de formule générale III sans isoler le produit intermé- Acetanilides of general formula III can also be prepared without isolating the intermediate product.
diaire de formule IV, en ajoutant, après l'hydrogéno- formula IV, adding, after hydrogenation,
alcanoylation, l'amine appropriée dans un solvant iner- alkanoylation, the appropriate amine in an inert solvent.
te à haut point d'ébullition, par exemple toluène ou high boiling point, for example toluene or
xylène, au mélange réactionnel et en chauffant. xylene, to the reaction mixture and heating.
Les composés de formule générale III dans les- Compounds of general formula III in
quels R est un amino peuvent être préparés par réduc- which R is an amino can be prepared by reducing
tion à partir des acétanilides de formule III corres- from the acetanilides of formula III corresponding to
pondants dans lesquels R est un nitro. in which R is a nitro.
Les acétanilides de formule III dans lesquels R est un halogène peuvent être préparés soit de la Acetanilides of formula III in which R is a halogen can be prepared either from
manière décrite plus haut à partir des anilides cor- described above from the corresponding anilides
respondantes, soit par la réaction de Sandmeyer à par- respondent, either by Sandmeyer's reaction to
tir des acétanilides dans lesquels R 4 est un amino. acetanilides in which R 4 is an amino.
On entend ici par radical basique un radical Here we mean by radical radical a radical
quelconque contenant au moins un atome d'azote basique. any one containing at least one basic nitrogen atom.
Dans le procédé de l'invention, on peut aussi éventuellement utiliser des catalyseurs L'homme de l'art peut facilement déterminer les températures et les durées de réaction qui conviennent On travaille habituellement à la pression atmosphérique normale, mais une pression supérieure inférieure à la normale n'est pas exclue ou In the process of the invention, it is also possible to use catalysts. Those skilled in the art can easily determine the temperatures and the reaction times which are suitable. It is usual to work at normal atmospheric pressure, but a lower pressure than the normal one. normal is not excluded or
Les composés nouveaux de formule III de l'in- The novel compounds of formula III of the invention
vention sont administrés de la manière usuelle pour are administered in the usual way for
les composés connus d'application analogue. known compounds of similar application.
Les formes de réalisation préférées ressortent The preferred embodiments stand out
des exemples suivants, dans lesquels sont aussi pré- examples which follow are also
sentés quelques produits de départ et produits inter- some of the starting materials and products
médiaires nouveaux.new medias.
A Avec isolement du produit intermédiaire de formule IV With isolation of the intermediate product of formula IV
EXEMPLE 1EXAMPLE 1
A un mélange de 53 g ( 0,35 mole) d'éthoxy-2 méthyl-6 aniline dans 525 ml d'acétone absolue et 7 o g de bicarbonate de sodium, on ajoute goutte à goutte en une heure, en refroidissant à la glace, 46 g ( 0,4 mole) de chlorure de chloracétyle, puis on agite une To a mixture of 53 g (0.35 mole) of 2-ethoxy-6-methyl-aniline in 525 ml of absolute acetone and 7 g of sodium bicarbonate is added dropwise over one hour, while cooling with ice-cream. 46 g (0.4 mole) of chloroacetyl chloride, followed by shaking a
heure à la température ambiante On aspire le sel mi- hour at room temperature We suck the salt half
néral et le lave à l'acétone On réduit le volume du and washes it with acetone. The volume of the
filtrat à la trompe à eau, on ajoute de l'au au rési- filtrate to the water pump, add to the
du et on aspire les cristaux séparés de chloro-2 of and one sucks the separated crystals of chloro-2
éthoxy-2 ' méthyl-6 ' acetanilide, point de fusion 148- 2'-ethoxy-6'-methyl-acetanilide, m.p.
149 C.149 C.
EXEMPLE 2EXAMPLE 2
En utilisant de la méthyl-2 nitro-6 aniline au lieu d'éthoxy-2 méthyl-6 aniline et en procédant Using 2-methyl-6-aniline aniline instead of 2-ethoxy-6-methyl-aniline and proceeding
comme dans l'exemple 1, on obtient du chloro-2 méthyl- as in Example 1, 2-chloromethyl is obtained.
2 ' nitro-6 ' acetanilide, point de fusion 140-141,5 C. 2 'nitro-6' acetanilide, m.p. 140-141.5 ° C.
Aminationamination
EXEMPLE 1EXAMPLE 1
A 10,25 g ( 0,045 mole) de chloro-2 éthoxy-2 ' To 10.25 g (0.045 mole) of 2-chloro-2-ethoxy
méthyl-6 ' acétanilide dans 100 ml de benzène, on ajou- 6-methylacetanilide in 100 ml of benzene is added.
te 10 g ( 0,136 mole) de diéthylamine et on fait bouil- 10 g (0.136 mole) of diethylamine are added and
lir le mélange à reflux pendant 6 heures Apres refroi- reflux the mixture for 6 hours after cooling
dissement, on aspire le chlorhydrate de diéthylamine séparé, on le lave au benzène et on réduit le volume du filtrat sous aspiration de trompe à eau On ajoute au résidu de l'eau et de l'éther, on extrait la base de la phase éther dans l'acide chlorhydrique à 5 %, on alcalinise la solution aqueuse acide et on agite avec de l'éther Apres séchage et évaporation de l'éther, on dissout le résidu dans l'éthanol et on ajoute goutte à goutte, en refroidissant, de l'acide chlorhydrique éthéré, et on obtient le chlorhydrate de diéthylamino-2 éthoxy-2 ' méthyl-6 ' acétanilide, The diethylamine hydrochloride salt is removed, washed with benzene and the volume of the filtrate is reduced under water suction. To the residue is added water and ether, the base is extracted from the ether phase. in 5% hydrochloric acid, the acidic aqueous solution is basified and stirred with ether After drying and evaporation of the ether, the residue is dissolved in ethanol and added dropwise with cooling, ethereal hydrochloric acid, and there is obtained 2-diethylamino-ethoxy-2'-methyl-6 'acetanilide hydrochloride,
point de fusion 107-109 C.melting point 107-109 C.
EXEMPLE 2EXAMPLE 2
En utilisant de la pipéridine au lieu de di- Using piperidine instead of di-
éthylamine et en procédant comme dans l'exemple 1, ethylamine and proceeding as in Example 1,
on obtient du pipéridino-2 éthoxy-2 ' méthyl-6 ' acéta- 2-piperidino-2'-ethoxy-6-methyl-acetyl acetate is obtained.
nilide, point de fusion 79-80 C, et on transforme la nilide, melting point 79-80 C, and the
base en chlorhydrate, point de fusion 192-193 C. base in hydrochloride, mp 192-193 C.
EXEMPLE 3EXAMPLE 3
En utilisant de la pyrrolidine au lieu de diéthylamine et en procédant comme à l'exemple 1,-k 5 Using pyrrolidine instead of diethylamine and proceeding as in Example 1,
obtient du pyrrolidino-2 éthoxy-2 ' méthyl-6 ' acétani- obtains 2-pyrrolidinethoxy-2'-methyl-6-acetanitrile
lide, point de fusion 60,5-62 C, qu'on transforme en lide, melting point 60.5-62 C, which is converted into
chlorhydrate, point de fusion 180-181,5 C. hydrochloride, mp 180-181.5 ° C.
EXEMPLE 4EXAMPLE 4
En partant de chloro-2 méthyl-2 ' nitro-6 ' acétanilide et de diéthylamine et en procédant comme Starting with 2-chloro-2'-methyl-6'-nitroacetanilide and diethylamine and proceeding as
dans l'exemple 1, on obtient le diéthylamino-2 méthyl- in Example 1, there is obtained 2-diethylamino-methyl
2 ' nitro-6 ' acétanilide, point de fusion 60-61 C, et son chlorhydrate, point de fusion 166-1680 C. 2 'nitro-6' acetanilide, m.p. 60-61 ° C, and its hydrochloride, mp 166-1680 ° C.
EXEMPLE 5EXAMPLE 5
En utilisant de la pipéridine au lieu de di- Using piperidine instead of di-
éthylamine et en procédant comme dans l'exemple 1, on obtient le pipéridino-2 méthyl-2 ' nitro-6 ' acétanilide, point de fusion 72-73 C, et son chlorhydrate, point ethylamine and proceeding as in Example 1, there is obtained 2-piperidino-2'-methyl-6'-nitroacetanilide, melting point 72-73 C, and its hydrochloride point
de fusion 192-194 C.192-194C fusion
EXEMPLE 6EXAMPLE 6
En partant de chloro-2 trifluorométhyl-2 ' acétanilide et de diéthylamine et en procédant comme Starting with 2-chloro-2-trifluoromethylacetanilide and diethylamine and proceeding as
dans l'exemple 1, on obtient le chlorhydrate de di- in Example 1, the dihydrochloride of
éthylamino-2 trifluorométhyl-2 ' acétanilide, point de 2-ethylamino-2-trifluoromethylacetanilide, point of
fusion 160,1 C.melting 160.1 C.
EXEMPLE 7EXAMPLE 7
En utilisant de la pyrrolidine au lieu de di- By using pyrrolidine instead of di-
éthylamine et en procédant comme dans les exemples 1 ethylamine and proceeding as in Examples 1
et 6, on obtient le chlorhydrate de pyrrolidino-2 tri- and 6, there is obtained 2-pyrrolidino hydrochloride
fluorométhyl-2 ' acétanilide, point de fusion 229,4 C. 2-fluoromethyl acetanilide, mp 229.4 ° C.
EXEMPLE 8EXAMPLE 8
En partant de chloro-2 propionyl-2 ' acétanili- Starting with 2-chloropropionyl-2 'acetaniline
de et de pyrrolidine et en procédant comme dans l'exem- ple 1, on obtient le chlorhydrate de pyrrolidino-2 of and of pyrrolidine and proceeding as in Example 1, we obtain the hydrochloride of pyrrolidino-2
propionyl-2 ' acétanilide.propionyl-2 'acetanilide.
EXEMPLE 9EXAMPLE 9
En partant de chloro-2 méthyl-2 ' propionyl-6 ' acétanilide et de pyrrolidine et en procédant comme Starting from 2-chloro-2-methyl-6'-propionylacetanilide and pyrrolidine and proceeding as
dans l'exemple 1, on obtient le chlorhydrate de pyrro- in Example 1, pyrrolidine hydrochloride is obtained
lidino-2 méthyl-2 ' propionyl 76 ' acetanilide, point de lidino-2-methyl-2 'propionyl 76' acetanilide, point of
fusion 192,6 C.192.6 C. fusion
On prépare la méthyl-2 propionyl-6 aniline uti- The 2-methylpropionyl-6-aniline used is prepared
lisée comme produit de départ à partir d'amino-2 méthyl-3 benzonitrile de la manière suivante On prépare le bromure d'éthyl-magnésium à partir de 6, 3 g ( 0,26 mole) de magnésium et 25,5 g de bromure d'éthyle dans 130 ml d'éther absolu et on le chauffe 30 minutes au bain-marie Ensuite, on ajoute goutte à goutte, lentement, une solution composée de 6,65 g ( 0,05 mole) d'amino-2 méthyl-3 benzonitrile As starting material from 2-amino-3-methylbenzonitrile was prepared as follows. Ethyl magnesium bromide was prepared from magnesium (6.3 g, 0.26 moles) and magnesium (25.5 g). ethyl bromide in 130 ml of absolute ether and heated for 30 minutes in a water bath Then, a solution consisting of 6.65 g (0.05 mole) of 2-amino-2 3-methylbenzonitrile
dans 100 ml d'éther absolu et on fait bouillir le mé- in 100 ml of absolute ether and boil the mixture
lange 15 heures à reflux avec agitation Après refroi- After 15 hours at reflux with stirring After cooling
dissement, on verse sur 110 g de glace et on ajoute une solution composée de 15,6 g de chlorure d'ammonium dans 67 ml d'eau On sépare la phase éther et on agite la phase aqueuse avec de l'éther On chasse par distillation l'éther des deux phases éther réunies et on fait bouillir 30 minutes à reflux le résidu avec The mixture is poured into ice (110 g) and a solution of 15.6 g of ammonium chloride in 67 ml of water is added. The ether phase is separated and the aqueous phase is stirred with ether. The two ether phases are distilled from the ether and the residue is boiled for 30 minutes.
9,5 ml d'eau et 11,2 ml d'acide chlordhydrique concen- 9.5 ml of water and 11.2 ml of concentrated hydrochloric acid
tré Après refroidissement, on agite avec de l'éther, on alcalinise la phase aqueuse et on extrait à l'éther Après séchage et évaporation de l'éther, on obtient la méthyl-2 propionyl-6 aniline, qu'on a After cooling, the mixture is stirred with ether, the aqueous phase is basified and the mixture is extracted with ether. After drying and evaporation of the ether, there is obtained 2-methylpropionyl-6-aniline, which is
caractérisée sous forme de chlorhydrate, point de fu- characterized in the form of hydrochloride, point of
sion 191,2 C.191.2 C.
EXEMPLE 10EXAMPLE 10
A 10,9 g ( 0,05 mole) de chloro-2 chloro-2 ' méthyl-6 ' acetanilide dans 30 ml de toluène absolu, on ajoute 12,75 g ( 0,15 mole) de cyclopentylamine dans 50 ml de toluène et on fait bouillir 6 heures à To 10.9 g (0.05 mol) of 2-chloro-2'-chloro-6'-methyl-acetanilide in 30 ml of absolute toluene, 12.75 g (0.15 mol) of cyclopentylamine in 50 ml of toluene are added. and boil 6 hours to
reflux Après refroidissement, on aspire le chlorhy- reflux After cooling, the chlorhy-
drate de cyclopentylamine séparé, on réduit le volume du filtrat et on ajoute au résidu de l'eau et de l'éther On extrait la phase éther et on ajoute une solution d'acide chlorhydrique à 5 %, de laquelle se Separated cyclopentylamine dearate, the volume of the filtrate is reduced and the residue is added with water and ether. The ether phase is extracted and a solution of 5% hydrochloric acid is added.
sépare par cristallisation le chlorhydrate de cyclopen- separates by crystallization the cyclopenyl hydrochloride
tylamino-2 chloro-2 ' méthyl-6 ' acetanilide, point de tylamino-2-chloro-2 'methyl-6' acetanilide, point of
fusion 209,7 C.melting 209.7 C.
On a préparé la base, point de fusion 76,8 C, The base was prepared, mp 76.8 ° C,
à partir de 1 g de chlorhydrate.from 1 g of hydrochloride.
EXEMPLE 11EXAMPLE 11
En ajoutant au chloro-2 chloro-2 ' méthyl-6 ' acétanilide de la cyclopropylamine dans le benzene, en chauffant 10 heures à 100 C dans un autoclave avec By adding 2-chloro-2-chloro-6-methyl-acetanilide cyclopropylamine in benzene, heating for 10 hours at 100 C in an autoclave with
revêtement intérieur en verre et, après refroidisse- inner lining of glass and, after cooling
ment, en procédant comme dans l'exemple 1, on obtient le chlorhydrate de cyclopropylamino-2 chloro-2 ' By following the procedure of Example 1, 2-cyclopropylamino-2-chlorohydrochloride is obtained.
méthyl-6 ' acétanilide, point de fusion 257 C. 6-methyl-acetanilide, m.p.
B Sans isolement du produit intermédiaire de formule IV B Without isolation of the intermediate product of formula IV
EXEMPLE 1EXAMPLE 1
A 18,6 g ( 0,1 mole) de bromo-2 méthyl-6 ani- To 18.6 g (0.1 mole) of 2-bromo-6-methyl-6-methyl
line dans 150 ml d'acétone absolue et 20 g de bicar- in 150 ml of absolute acetone and 20 g of bicarbonate.
bonate de sodium, on ajoute goutte à goutte en une heure, en refroidissant à la glace, 12 g ( 0,11 mole) de chlorure de chloracétyle, puis on agite 30 minutes à la température ambiante On ajoute au mélange 22 g ( 0,3 mole) de diéthylamine dans 50 ml de toluene et on fait bouillir 6 heures à reflux On procède ensuite sodium chloride, 12 g (0.11 mol) of chloroacetyl chloride are added dropwise over one hour, while cooling with ice, and the mixture is then stirred for 30 minutes at room temperature. 22 g (0.degree. 3 mol) of diethylamine in 50 ml of toluene and boiled for 6 hours at reflux.
comme en A, exemple 1.as in A, example 1.
On obtient le chlorhydrate de diéthylamino-2 Diethylamino-2 hydrochloride is obtained
bromo-2 ' méthyl-6 ' acetanilide, point de fusion 172- 2'-bromo-6-methylacetanilide, m.p.
174 C.174 C.
a) On peut préparer la même diéthylamino-2 a) The same diethylamino-2 can be prepared
bromo-2 ' méthyl-6 ' acetanilide à partir de diéthylami- 2'-bromo-6-methylacetanilide from diethylamine
no-2 amino-2 ' méthyl-6 ' acétanilide par la réaction de Sandmeyer de la manière suivante: On refroidit en bain de glace 11,75 g ( 0,05 mole) de diéthylamino-2 amino-2 ' méthyl-6 ' acétanilide dans 30 ml d'acide bromhydrique à 48 % et on diazote à -5 C pendant 30 minutes avec 3,45 g de nitrite de sodium dans 20 ml d'eau (contrôle au papier à l'amidon No. 2-amino-2'-methyl-6-acetanilide by the Sandmeyer reaction as follows: 11.75 g (0.05 mole) of 2-diethylamino-2-amino-6-methyl-amine are cooled in an ice-bath acetanilide in 30 ml of 48% hydrobromic acid and is diazotized at -5 ° C. for 30 minutes with 3.45 g of sodium nitrite in 20 ml of water (starch paper control)
iodé), puis on agite 40 minutes à -5 C On ajoute len- iodine), then stirred for 40 minutes at -5 ° C.
tement la suspension à un mélange chauffé à 70 C de 4 g de Cu Br dans 20 ml d'acide bromhydrique à 48 % et the suspension to a mixture heated at 70 ° C. with 4 g of CuBr in 20 ml of 48% hydrobromic acid and
on agite 2 heures à cette température Apres refroi- stirring for 2 hours at this temperature After cooling
dissement, on agite avec de l'éther, on alcalinise la solution acide et on extrait à l'éther Apres séchage et évaporation de l'éther, on dissout le résidu dans The mixture is stirred with ether and the acid solution is made alkaline and extracted with ether. After drying and evaporation of the ether, the residue is dissolved in
l'éthanol et on le transforme avec du chlorure d'hydro- ethanol and transform it with hydrochloric acid
gène éthéré en chlorhydrate, qui est identique au pro- ethereal gene in hydrochloride, which is identical to
duit indiqué dans l'exemple 1, point de fusion 172- as shown in Example 1, melting point 172-
1740 C.1740 C.
Réduction de diéthylamino-2 et pipéridino-2 méthyl-2 ' nitro-6 ' acétanilidesv Reduction of 2-diethylamino and 2-piperidino-2-methyl-6-nitroacetanilide
EXEMPLE 1EXAMPLE 1
a) A 25 g ( 0,094 mole) de diéthylamino-2 méthyl-2 ' nitro-6 ' acétanilide dans 500 ml d'acide chlorhydrique concentré, on ajoute en une heure, en agitant, 100 g de chlorure d'étain (II) On chauffe le mélange 30 minutes au bain-marie bouillant et, après refroidissement, on alcalinise avec une solution de soude à 35 % en refroidissant à la glace et on a) To 25 g (0.094 mol) of 2-diethylamino-2-methyl-6'-nitroacetanilide in 500 ml of concentrated hydrochloric acid, 100 g of tin (II) chloride are added in one hour with stirring. The mixture is heated for 30 minutes in a boiling water bath and, after cooling, basified with 35% sodium hydroxide solution while cooling with ice and
extrait à l'éther Après lavage, séchage et évapora- extracted with ether After washing, drying and evaporation
tion de l'éther, on obtient le diéthylamino-2 amino- ether, 2-ethyl-2-diethylamino is obtained.
2 ' méthyl-6 ' acetanilide, point de fusion 105-106,5 C, qu'on transforme avec du chlorure d'hydrogène éthéré en dichlorhydrate, point de fusion 182-184 C. b) On obtient aussi le même diéthylamino-2 2-methyl-6'-acetanilide, mp 105-106.5 ° C, which is converted with ethereal hydrogen chloride to dihydrochloride, mp 182 ° -184 ° C. b) The same diethylamino-2 is also obtained
amino-2 ' méthyl-6 ' acétanilide de la manière suivante. 2'-Amino-6-methylacetanilide as follows.
A un mélange de 300 mg de Pd-C dans 60 ml d'eau balayé par un courant d'azote, on ajoute 4,8 g d'hydrure de sodium-bore dans 90 ml d'eau Ensuite, on ajoute goutte à goutte en 30 minutes la solution composée de 15,9 g ( 0,06 mole) de diéthylamino-2 méthyl-2 ' nitro-6 ' acetanilide dans 150 ml de méthanol puis on agite pendant encore 20 minutes On filtre, on réduit le volume du filtrat à la trompe à eau, on ajoute de l'eau et on aspire les cristaux séparés, To a mixture of 300 mg of Pd-C in 60 ml of water flushed with a nitrogen stream, 4.8 g of sodium boron hydride in 90 ml of water are added. Then, dropwise is added dropwise. in 30 minutes the solution consisting of 15.9 g (0.06 mol) of 2-diethylamino-2-methyl-6'-nitroacetanilide in 150 ml of methanol and then stirring for a further 20 minutes is filtered, the volume of the water-jet filtrate, water is added and the separated crystals are aspirated,
point de fusion 105-106,5 C.melting point 105-106.5 C.
EXEMPLE 2EXAMPLE 2
On prépare le pipéridino-2 amino-2 ' méthyl-6 ' acetanilide, point de fusion 169-170 C, en procédant 2-piperidino-2-amino-2'-methyl-6'-acetanilide, melting point 169-170 ° C., is prepared by proceeding
comme dans l'exemple lb, excepté qu'on chauffe le mé- as in Example lb, except that the heat is
lange avant la filtration, car le produit est peu soluble dans le méthanol froid On dissout la base dans l'éthanol et on la transforme avec de l'acide before the filtration, because the product is not very soluble in cold methanol The base is dissolved in ethanol and transformed with acid
chlorhydrique éthéré en dichlorhydrate, point de fu- ethereal hydrochloric acid to dihydrochloride,
sion 259-260 C.259-260 C.
Claims (8)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH5116/82A CH650768A5 (en) | 1982-08-27 | 1982-08-27 | BASIC ACETANILIDES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE ACETANILIDES. |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2532306A1 true FR2532306A1 (en) | 1984-03-02 |
FR2532306B1 FR2532306B1 (en) | 1989-03-10 |
Family
ID=4288192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR838313761A Expired FR2532306B1 (en) | 1982-08-27 | 1983-08-26 | BASIC ACETANILIDES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM |
Country Status (8)
Country | Link |
---|---|
JP (1) | JPS59130250A (en) |
CA (1) | CA1214776A (en) |
CH (1) | CH650768A5 (en) |
DE (1) | DE3328186A1 (en) |
FR (1) | FR2532306B1 (en) |
GB (1) | GB2129424B (en) |
IT (1) | IT1168212B (en) |
SE (1) | SE8304456L (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7067666B2 (en) * | 2003-06-27 | 2006-06-27 | Research Triangle Institute | 7-substituted camptothecin and camptothecin analogs and methods for producing the same |
BRPI0404222A (en) * | 2004-06-07 | 2006-02-07 | Fundacao Oswaldo Cruz | Lidocaine derivatives, pharmaceutical compositions containing them, use of the respective pharmaceutical compositions in the treatment, prevention or inhibition of diseases as well as the method of treating, preventing or inhibiting diseases with said pharmaceutical compositions |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE517755A (en) * | ||||
BE534406A (en) * | ||||
US2689853A (en) * | 1954-09-21 | Certain i | ||
CH306793A (en) * | 1955-04-30 | 1955-04-30 | Cilag Ag | Process for making a new salt. |
DE1005075B (en) * | 1952-08-18 | 1957-03-28 | Hoechst Ag | Process for the production of new locally anesthetically acting, basic substituted carboxamides |
CH329572A (en) * | 1954-07-29 | 1958-04-30 | Cilag Ag | Process for the preparation of basic amides |
US2948736A (en) * | 1957-08-05 | 1960-08-09 | Cilag Chemie | New anilides and process for their production |
DE1125713B (en) * | 1960-03-23 | 1962-03-15 | Bayer Ag | Pest repellants |
DE2129960A1 (en) * | 1970-06-16 | 1971-12-30 | May & Baker Ltd | Benzene derivatives |
CH582669A5 (en) * | 1971-12-13 | 1976-12-15 | Sumitomo Chemical Co | |
FR2336079A1 (en) * | 1975-12-23 | 1977-07-22 | Ciba Geigy Ag | NEW PLANT GROWTH REGULATORS, BASED ON ANILIDES OF QUATERNARY-ALKANOIC AMMONIUM ACIDS |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB859355A (en) * | ||||
NL73080C (en) * | 1950-03-03 | |||
GB726864A (en) * | 1952-05-13 | 1955-03-23 | Geistlich Soehne Ag | New ª‰-dialkyl-aminobutyric acid anilide derivatives and a process for preparing thesame |
GB782971A (en) * | 1952-08-18 | 1957-09-18 | Hoechst Ag | Basically substituted carboxylic acid amides and a process for making them |
GB726050A (en) * | 1953-10-16 | 1955-03-16 | James Arthur Cooke | A holder for chisels and plane irons whilst honing |
GB759744A (en) * | 1953-12-24 | 1956-10-24 | Cilag Ltd | Process for the production of mono- and di-substituted amino fatty acid-2-halogeno-6-methyl-anilides |
GB809286A (en) * | 1954-07-05 | 1959-02-18 | Hoechst Ag | Basically substituted butyric acid anilides and process for their manufacture |
NL6704169A (en) * | 1966-04-06 | 1967-10-09 | ||
GB1187118A (en) * | 1967-07-06 | 1970-04-08 | Shell Int Research | Electrodeposition of Synthetic Resin Coatings |
GB1514151A (en) * | 1977-01-24 | 1978-06-14 | Gallardo Antonio Sa | Piperidine derivatives |
-
1982
- 1982-08-27 CH CH5116/82A patent/CH650768A5/en not_active IP Right Cessation
-
1983
- 1983-08-01 DE DE19833328186 patent/DE3328186A1/en not_active Withdrawn
- 1983-08-15 GB GB08321953A patent/GB2129424B/en not_active Expired
- 1983-08-17 SE SE8304456A patent/SE8304456L/en not_active Application Discontinuation
- 1983-08-26 CA CA000435457A patent/CA1214776A/en not_active Expired
- 1983-08-26 IT IT48886/83A patent/IT1168212B/en active
- 1983-08-26 FR FR838313761A patent/FR2532306B1/en not_active Expired
- 1983-08-27 JP JP58157050A patent/JPS59130250A/en active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE517755A (en) * | ||||
BE534406A (en) * | ||||
US2689853A (en) * | 1954-09-21 | Certain i | ||
DE1005075B (en) * | 1952-08-18 | 1957-03-28 | Hoechst Ag | Process for the production of new locally anesthetically acting, basic substituted carboxamides |
CH329572A (en) * | 1954-07-29 | 1958-04-30 | Cilag Ag | Process for the preparation of basic amides |
CH306793A (en) * | 1955-04-30 | 1955-04-30 | Cilag Ag | Process for making a new salt. |
US2948736A (en) * | 1957-08-05 | 1960-08-09 | Cilag Chemie | New anilides and process for their production |
DE1125713B (en) * | 1960-03-23 | 1962-03-15 | Bayer Ag | Pest repellants |
DE2129960A1 (en) * | 1970-06-16 | 1971-12-30 | May & Baker Ltd | Benzene derivatives |
CH582669A5 (en) * | 1971-12-13 | 1976-12-15 | Sumitomo Chemical Co | |
FR2336079A1 (en) * | 1975-12-23 | 1977-07-22 | Ciba Geigy Ag | NEW PLANT GROWTH REGULATORS, BASED ON ANILIDES OF QUATERNARY-ALKANOIC AMMONIUM ACIDS |
Non-Patent Citations (13)
Title |
---|
CHEMICAL ABSTRACTS, vol. 35, no. 7, 10 avril 1941, colonnes 2125.9-2126.5 COLUMBUS OHIO (US) * |
CHEMICAL ABSTRACTS, vol. 43, no. 3, 10 février 1949, colonnes 1021e-1022c COLUMBUS OHIO (US) * |
CHEMICAL ABSTRACTS, vol. 43, no. 3, 10 février 1949, colonnes 1023d-1024f COLUMBUS OHIO (US) * |
CHEMICAL ABSTRACTS, vol. 47, no. 18, 25 septembre 1953, colonnes 9284i - 9285g COLUMBUS OHIO (US) * |
CHEMICAL ABSTRACTS, vol. 48, no. 15, 10 août 1954, colonnes 8939 c-f COLUMBUS OHIO (US) * |
CHEMICAL ABSTRACTS, vol. 50, no. 1, 10 janvier 1956, colonnes 209b-210b COLUMBUS OHIO (US) * |
CHEMICAL ABSTRACTS, vol. 50, no. 19, 10 octobre 1956, colonnes 13773 a-g COLUMBUS OHIO (US) * |
CHEMICAL ABSTRACTS, vol. 55, no. 11, 29 mai 1961, colonnes 10712i - 10713b COLUMBUS OHIO (US) * |
CHEMICAL ABSTRACTS, vol. 96, no. 23, 7 juin 1982, page 20, résumé no. 192922d COLUMBUS OHIO (US) * |
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 65, décembre 1943 WASHINGTON D.C. (US) * |
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 76, 5 mars 1954 WASHINGTON D.C. (US) * |
PHARMAZIE, vol. 28, no. 6, 1973 BERLIN (DE) * |
PHARMAZIE, vol. 32, no. 8,9, 1977 BERLIN (DE) * |
Also Published As
Publication number | Publication date |
---|---|
JPS59130250A (en) | 1984-07-26 |
CA1214776A (en) | 1986-12-02 |
DE3328186A1 (en) | 1984-03-01 |
FR2532306B1 (en) | 1989-03-10 |
SE8304456L (en) | 1984-02-28 |
SE8304456D0 (en) | 1983-08-17 |
IT8348886A0 (en) | 1983-08-26 |
CH650768A5 (en) | 1985-08-15 |
GB8321953D0 (en) | 1983-09-14 |
GB2129424A (en) | 1984-05-16 |
IT1168212B (en) | 1987-05-20 |
GB2129424B (en) | 1986-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH375017A (en) | Process for the preparation of novel imidazole derivatives | |
EP0200638B1 (en) | Process for the preparation of (z)-1-phenyl-1-diethyl amino carbonyl 2-amino methyl cyclopropane hydrochloride | |
US4767882A (en) | Tetrahydronaphthalene derivatives and their production | |
FR2472564A1 (en) | 1-Aryl-4-aryl:sulphonyl-3-amino-propoxy-1H-pyrazole derivs. - hypolipaemics and hypocholesterolaemics of low toxicity and non-ulcerogenic | |
EP0283761A1 (en) | Chromone derivatives | |
FR2532306A1 (en) | BASIC ACETANILIDES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THE SAME | |
NO145209B (en) | APPARATUS FOR MAGNETIC EFFECT OF A FLOWING LIQUID | |
CH615414A5 (en) | ||
FR2600647A1 (en) | GLYCINE DERIVATIVES | |
EP0196943B1 (en) | 8-thiotetrahydroquinoleine derivatives and their salts | |
FR2602228A1 (en) | New phenoxyisobutyric acids, their derivatives and processes for producing them | |
JP2600327B2 (en) | Optically active carboxylic acid esters and method for producing the same | |
CH313377A (en) | Process for the preparation of novel phenothiazine derivatives | |
BE858864A (en) | NEW ESTERS OF PHENYL- AND PYRIDINE-3-CARBOXYLIC ACIDS AND PROCESS FOR THEIR PREPARATION | |
FR2699172A1 (en) | Novel 4-methyl-1,3-oxazole derivatives, process for their preparation and pharmaceutical compositions containing them | |
CH592665A5 (en) | 7H-Indolizino (5,6,7-i,j)-isoquinolines - as antibilharzial, anthelmintic and antimicrobial agents | |
FR2532304A1 (en) | BASIC ESTERS OF BENZOIC ACIDS AND THIOPHENECARBOXYLIC ACIDS-2, PROCESSES FOR THE PREPARATION THEREOF AND MEDICAMENTS CONTAINING THE SAME | |
CH382167A (en) | Process for the preparation of 5-hydroxymethyl-2-oxazolidone ethers | |
FR2753968A1 (en) | NOVEL HETEROARYLOXYETHYLAMINES, PROCESS FOR THE PREPARATION THEREOF, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | |
BE508785A (en) | ||
CH401064A (en) | Process for the preparation of new phenothiazines | |
CH622252A5 (en) | Process for the preparation of new 1-nitrophenyl-1H,3H-quinazoline-2,4-diones | |
CH286106A (en) | Process for preparing an aromatic acylamidodiol, nitrated in the nucleus. | |
CH288947A (en) | Process for preparing an aromatic acylamidodiol. | |
CH396913A (en) | Process for the preparation of new phenothiazines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |